Kenvue
Preis: 18.07Unternehmen und Geschäftsmodell
Kenvue (KVUE.US) operates in the consumer staples sector, focusing on personal care and hygiene products. Its core offerings include over-the-counter medications, skincare, and household cleaning products. Major business segments encompass health and wellness, beauty, and home care, with primary revenue sources derived from product sales in retail and e-commerce channels.
Anlageprofil
The investment profile of Kenvue is more aligned with dividend investors due to its notable dividend yield of 6.0%. The stock exhibits moderate growth potential, making it suitable for those seeking a balance between income and capital appreciation. Its relatively stable performance and low volatility suggest a lower risk profile, appealing to investors with a medium to long-term horizon.
Fundamentale Kennzahlen (experimentell)
- EPS (TTM) — Gewinn pro Aktie der letzten 12 Monate, $
- 0.85 OK
- Umsatz QoQ — Umsatzwachstum im Quartalsvergleich
- 3.4% ↑
- EPS-Überraschung
- 18.5% besser als erwartet
- 20d Volatilität
- 1.6% stabil
- Dividendenrendite
- 4.6% hoch letzter Ex-Tag: 2026-05-13
Im Portfolio verfolgen
Preischart
| Datum | Vorher | Nachher | Grund |
|---|---|---|---|
| 2026-06-10 00:48 | Halten | Kaufen | Strong fundamentals and solid dividend yield support growth. |
| 2026-05-30 02:43 | Kaufen | Halten | Stable dividend, but weak momentum and high risk. |
| 2026-05-22 02:50 | Halten | Kaufen | Stable dividend, moderate growth, mixed momentum signals. |
| Datum | Analyst | Action | Ziel | Preis damals |
|---|---|---|---|---|
| 2026-04-14 12:53 | Barclays | Ziel gesenkt | 19 → 18 | 17.385 |
| 2026-02-18 12:42 | UBS | Ziel erhöht | 17 → 19 | 18.41 |
| 2026-02-18 12:10 | Canaccord Genuity | Ziel erhöht | 17 → 18 | 18.41 |
Noch nichts